BioWorld-International-2005-05-18
NovImmune, Serono Enter Antibody Deal Worth $122M
NovImmune, Serono Enter Antibody Deal Worth $122M
NovImmune SA entered its first product out-licensing pact, a deal with Serono SA, which is potentially worth up to $122 million for two preclinical fully human antibodies, NI-0401 and NI-0501. (BioWorld International)

